| Literature DB >> 26758788 |
Thomas Seufferlein1, Julia Mayerle2.
Abstract
Late diagnosis and an inability to personalize treatment are major problems preventing reductions in pancreatic cancer mortality. In 2015, the identification of a highly discriminatory exosomal biomarker, culture systems that recapitulate human disease and new methods of analysing large data sets to identify prognostic markers have improved the future outlook for patients with this cancer.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26758788 DOI： 10.1038/nrgastro.2015.215
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802